The n-3 PUFA supplementation for 6 months in patients after the first episode of schizophrenia was associated with an increased level of BDNF, but no effect on BDNF was recorded in patients with posttraumatic stress disorder or depression [16–18]. The gene discussed is BDNF; the disease is depressive symptom measurement.